University of Washington

General Electric Company

Bl Technologies, Inc.

Cytiva Sweden Ab

Louisa Ruth Carr

Shaoyi Jiang

Hong Xue

Patrick Joseph McCloskey

James Manio Silva

Julia L Lee

Paul Michael Smigelski, Jr

David Roger Moore

Matthew Jeremiah Misner

Hongyi Zhou

Zheng Zhang

Shengfu Chen

Cathryn Ellen Olsen

Jason Michael Nichols

Paul Michael Smigelski

Wei Yang

Gang Cheng

Julia Lam Lee

Patrick Joseph Mccloskey

Provided herein are copolymers and copolymer compositions that are both hydrophilic and oleophobic. The copolymers include structural units derived from a fluoroalkyl monomer and a zwitterionic monomer. It further relates to membranes formed by coating a porous substrate with the copolymeric compositions. The copolymeric coating imparts hydrophilicity and oleophobicity/oil-tolerance to the membranes. The uses of such membranes as microfiltration membrane or ultrafiltration membrane are also provided.

Hydrophilic-oleophobic copolymer composition and uses thereof

A membrane including a block copolymer is presented. The block copolymer includes at least one block A including structural units having a formula (I), and at least one block B including structural units having a formula (II). A hollow-fiber membrane for hemodialysis or hemofiltration, and associated block copolymer are also presented.

Zwitterion-functionalized block copolymer membranes and associated block copolymer composition

Zwitterionic crosslinking agents, crosslinked zwitterionic hydrogels prepared from copolymerization of zwitterionic monomers with the zwitterionic crosslinking agent, methods for making crosslinked zwitterionic hydrogels, and devices that include and methods that use the crosslinked zwitterionic hydrogels.

Crosslinked mixed charge hydrogels

Crosslinked zwitterionic hydrogels

Cationic polymers hydrolyzable to zwitterionic polymers, monomers for making the cationic polymers, surfaces that include the polymers, therapeutic agent delivery systems that include the cationic polymers, methods for administering a therapeutic agent using the delivery systems, and methods for making and using the cationic polymers, monomers, surfaces, and therapeutic agent delivery systems.

Cationic betaine precursors to zwitterionic betaines having controlled biological properties

Growing community of inventors

Schenectady, NY, United States of America

Louisa Ruth Carr